NCT03919721 is a NA clinical trial of Applied Behavioral Analysis in Autistic Disorder, sponsored by Experiad LLC.

Who is sponsoring NCT03919721?

NCT03919721 is sponsored by Experiad LLC.

What drugs are being tested in NCT03919721?

Interventions in NCT03919721: Applied Behavioral Analysis.

What condition does NCT03919721 study?

NCT03919721 studies Autistic Disorder.

Is NCT03919721 still recruiting?

NCT03919721 is currently status unknown. Last updated 18 April 2019.

Last reviewed 2019-04-18 · How we verify

NCT03919721

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Field Test of Motivity.Net Software for Data Collection During Behavioral Interventions

Status unknown NA Last updated 18 April 2019

What this trial tests

NA trial testing Applied Behavioral Analysis in Autistic Disorder in 12 participants. Status unknown.

Timeline

1 November 2019

Primary endpoint
31 March 2020

31 March 2020

Quick facts

Lead sponsor	Experiad LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	12
Start date	1 November 2019
Primary completion	31 March 2020
Estimated completion	31 March 2020
Sites	1 location across United States

Drugs / interventions tested

Applied Behavioral Analysis

Conditions studied

Autistic Disorder — all drugs for Autistic Disorder →

Sponsor

Experiad LLC

Who can join

Adults 2 to 21, any sex, with Autistic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study funded by a Phase II SBIR to build and test the feasibility of a new software prototype for delivering evidence-based behavioral therapy treatment for autism. The software, called Motivity.net, will be used by behavioral therapy provider groups across the country to manage the intensive data collection and analysis workflow associated with Applied Behavioral Analysis (ABA) and related therapies, which are becoming standard-of-care treatment for children with autism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autistic Disorder

Currently open trials in the same condition.

NCT05910502 — Project AFECT (Autism Family Empowerment Coaching and Training Program) · NA · active not recruiting
NCT06227780 — Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders · NA · recruiting
NCT05176808 — Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD) · NA · recruiting

Other Experiad LLC trials

Trials by the same sponsor.

NCT06561581 — Acuity Functional Impact and Implementation Outcomes Evaluation · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03919721 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Experiad LLC
Last refreshed: 18 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03919721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing